Detalles de la búsqueda
1.
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Cancer Immunol Immunother
; 73(6): 106, 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38634928
2.
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.
Cancer Immunol Immunother
; 72(9): 2961-2970, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37248424
3.
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.
Cancer Immunol Immunother
; 72(11): 3665-3682, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37676282
4.
Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment Landscape: Insights from Italian Experts.
Curr Oncol Rep
; 25(11): 1345-1362, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37855848
5.
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a).
Int J Mol Sci
; 24(2)2023 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36674615
6.
Is Systemic Immune-Inflammation Index a Real Non-Invasive Biomarker to Predict Oncological Outcomes in Patients Eligible for Radical Cystectomy?
Medicina (Kaunas)
; 59(12)2023 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38138166
7.
Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer.
N Engl J Med
; 381(26): 2506-2518, 2019 12 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31566937
8.
Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study.
Lancet Oncol
; 21(11): 1513-1525, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32926841
9.
Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results.
J Transl Med
; 17(1): 296, 2019 08 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31464635
10.
Cabozantinib-related cardiotoxicity: a prospective analysis in a real-world cohort of metastatic renal cell carcinoma patients.
Br J Clin Pharmacol
; 85(6): 1283-1289, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30740760
11.
The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma.
Anticancer Drugs
; 29(7): 705-709, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29846246
12.
Positive Association between Preoperative Total Testosterone Levels and Risk of Positive Surgical Margins by Prostate Cancer: Results in 476 Consecutive Patients Treated Only by Radical Prostatectomy.
Urol Int
; 101(1): 38-46, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29975957
13.
Prognostic role of the cumulative toxicity in patients affected by metastatic renal cells carcinoma and treated with first-line tyrosine kinase inhibitors.
Anticancer Drugs
; 28(2): 206-212, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27754995
14.
The origin of prostate metastases: emerging insights.
Cancer Metastasis Rev
; 34(4): 765-73, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26363603
15.
Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 2 - prostate and bladder cancer.
Future Oncol
; 12(17): 1971-4, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27312584
16.
Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 1 - kidney cancer.
Future Oncol
; 12(17): 1967-70, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27312426
17.
Serum HER2 extracellular domain levels and HER2 circulating tumor cell status in patients with metastatic breast cancer.
Future Oncol
; 12(17): 2001-8, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27255717
18.
Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trials.
Int J Cancer
; 136(1): 1-10, 2015 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24415642
19.
Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab.
Int J Cancer
; 137(6): 1467-74, 2015 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25704501
20.
Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside.
Cancer Metastasis Rev
; 33(1): 321-31, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24337954